Reorganization of public procurement of biosimilars and its economic effect on the monoclonal antibody market in Russia
Background. The increasing number of registered biosimilars of monoclonal antibodies (mAbs) is altering the structure of the pharmaceutical market by amplifying the share of domestic manufacturers. Therefore, investigating their economic effect appears highly relevant.Objective: To examine the impac...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
IRBIS LLC
2025-05-01
|
| Col·lecció: | Фармакоэкономика |
| Matèries: | |
| Accés en línia: | https://www.pharmacoeconomics.ru/jour/article/view/1145 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|